NAGE Niagen Bioscience Inc
Healthcare$3.90+0.00%OpenMarket Cap: $310.2M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$10.50
Target (Median)
$10.50
Target Range
$10.00 - $11.00
Upside from current price: 169.6%
Rating Distribution
0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-11 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-05 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-03-31 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-11-05 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-08-11 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-06-10 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-06-06 | Roth Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Wed Dec 31 | $0.18 | $127.3M | 3 |
| Thu Dec 31 | $0.23 | $142.3M | 4 |
| Fri Dec 31 | $0.31 | $166.9M | 3 |
| Sun Dec 31 | $0.42 | $203.4M | 2 |